Wang Jun, Xu Qiancheng, Li Juan, Wang Tao, Zhong Changshun, Chen Qun, Fang Ke, Jiang Haijiao, Zhang Peng, Lu Weihua, Jiang Xiaogan
Department of Critical Care Medicine, the First Affiliated Hospital of Wannan Medical College, Yijishan Hospital, Anhui Provincial Clinical Research Center for Critical Respiratory Disease, Wuhu 241000, Anhui, China.
Department of Nephrology, Wuhu Hospital Affiliated to East China Normal University (the Second People's Hospital of Wuhu), Wuhu 241000, Anhui, China. Corresponding author: Jiang Xiaogan, Email:
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2022 Apr;34(4):388-393. doi: 10.3760/cma.j.cn121430-20210824-01261.
To investigate the effects of different connection schemes of continuous renal replacement therapy (CRRT) and extracorporeal membrane oxygenation (ECMO) on arterial pressure (PA), venous pressure (PV), and transmembrane pressure (TMP), and to provide a theoretical basis for choosing a suitable connection scheme.
(1) In vitro study: the different connection schemes of CRRT and ECMO were simulated and divided into 6 schemes according to the connection between CRRT and ECMO circuits at different positions. Scheme A: connected to the front and back points of the oxygenator; scheme B: connected to the points behind and in front of the oxygenator; scheme C: connected to the points in front of the oxygenator and in front of the centrifugal pump; scheme D: connected to the points behind the oxygenator and in front of the centrifugal pump; scheme E: connected to the points in front of the oxygenator and the return catheter; scheme F: connected to the points after the oxygenator and the return catheter. Each set of ECMO circuits was measured 5 times under each connection scheme and different flow rates (2, 3, 4, 5, 5.5 L/min). Six ECMO circuits for a total of 30 measurements, and the PA, PV, and TMP of the 6 schemes were compared. (2) In vivo study: the patients who were treated with ECMO combined with CRRT in the department of critical care medicine of the First Affiliated Hospital of Wannan Medical College from August 2017 to August 2021 changed the connection scheme due to high PA or PV (from scheme A or B to scheme E or F) were retrospectively analyzed. The changes of PA and PV before and after changing the scheme were compared.
(1) In vitro study results: there was no significant difference in PA between schemes A and B, C and D, E and F under different ECMO blood flow (2-5.5 L/min). The PA of schemes C and D was the lowest, followed by schemes E and F. PV of scheme B was higher than that of scheme A under different ECMO blood flow (2-5.5 L/min). There was no significant difference in PV between schemes C and D, E and F under high ECMO blood flow (3-5.5 L/min), and the absolute value of PV was lowest in schemes E and F. Compared with schemes A and B [partial PA > 300 mmHg (1 mmHg ≈ 0.133 kPa) at high flow rate], C and D (partial PV > 350 mmHg at high flow rate), schemes E and F were more reasonable connection schemes. TMP was negative in schemes C and D at ECMO blood flow of 5 L/min and 5.5 L/min (mmHg; 5 L/min: scheme C was -29.14±11.42, scheme D was -42.45±15.70; 5.5 L/min: scheme C was -35.75±13.21, scheme D was -41.58±15.42), which indicated the presence of dialysate reverse filtration. Most of the differences in TMP among schemes A, B, E, and F under different ECMO blood flow (2-5.5 L/min) were statistically significant, and the absolute value of mean fluctuation was 9.89-49.55 mmHg, all within the normal range. (2) In vivo study results: a total of 10 patients who changed the connection scheme (from scheme A or B to E or F) due to high PA or PV were enrolled, including 8 males and 2 females; 7 cases of venous-arterial ECMO (VA-ECMO) and 3 cases of venous-venous ECMO (VV-ECMO), all used continuous veno-venous hemodiafiltration (CVVHDF) mode. After changing the scheme, both PA and PV decreased significantly as compared with those before changing [PA (mmHg): 244.00±22.58 vs. 257.20±21.92, PV (mmHg): 257.20±18.43 vs. 326.40±15.41, both P < 0.01], and PV decreased more significantly than PA [difference (mmHg): 69.20±6.55 vs. 13.20±5.45, P < 0.01].
For patients treated with ECMO in combination with CRRT, the scheme of connecting the access line of CRRT to the pre-oxygenator or post-oxygenator and connecting the return line to the point of the return catheter can significantly reduce PA and PV and maintains normal CRRT operation even running high-flow ECMO.
探讨连续性肾脏替代治疗(CRRT)与体外膜肺氧合(ECMO)不同连接方案对动脉压(PA)、静脉压(PV)和跨膜压(TMP)的影响,为选择合适的连接方案提供理论依据。
(1)体外研究:模拟CRRT与ECMO的不同连接方案,根据CRRT与ECMO回路在不同位置的连接情况分为6种方案。方案A:连接至氧合器前后点;方案B:连接至氧合器后前点;方案C:连接至氧合器前和离心泵前点;方案D:连接至氧合器后和离心泵前点;方案E:连接至氧合器前和回血导管点;方案F:连接至氧合器后和回血导管点。在每种连接方案及不同流速(2、3、4、5、5.5 L/min)下,对每组ECMO回路进行5次测量。6个ECMO回路共测量30次,比较6种方案的PA、PV和TMP。(2)体内研究:回顾性分析2017年8月至2021年8月在皖南医学院第一附属医院重症医学科接受ECMO联合CRRT治疗的患者,因PA或PV过高而改变连接方案(从方案A或B改为方案E或F)的情况。比较方案改变前后PA和PV的变化。
(1)体外研究结果:在不同ECMO血流(2 - 5.5 L/min)下,方案A与B、C与D、E与F之间的PA无显著差异。方案C和D的PA最低,其次是方案E和F。在不同ECMO血流(2 - 5.5 L/min)下,方案B的PV高于方案A。在高ECMO血流(3 - 5.5 L/min)下,方案C和D、E和F之间的PV无显著差异,方案E和F的PV绝对值最低。与方案A和B [高流速时部分PA > 300 mmHg(1 mmHg≈0.133 kPa)]、C和D(高流速时部分PV > 350 mmHg)相比,方案E和F是更合理的连接方案。在ECMO血流为5 L/min和5.5 L/min时,方案C和D的TMP为负值(mmHg;5 L/min:方案C为-29.14±11.42,方案D为-42.45±15.70;5.5 L/min:方案C为-35.75±13.21,方案D为-41.58±15.42),提示存在透析液反滤。在不同ECMO血流(2 - 5.5 L/min)下,方案A、B、E和F之间TMP的大部分差异具有统计学意义,平均波动绝对值为9.89 - 49.55 mmHg,均在正常范围内。(2)体内研究结果:共纳入10例因PA或PV过高而改变连接方案(从方案A或B改为E或F)的患者,其中男性8例,女性2例;7例静脉-动脉ECMO(VA-ECMO),3例静脉-静脉ECMO(VV-ECMO),均采用连续性静脉-静脉血液透析滤过(CVVHDF)模式。方案改变后,PA和PV均较改变前显著降低[PA(mmHg):244.00±22.58 vs. 257.20±21.92,PV(mmHg):257.20±18.43 vs. 326.40±15.41,均P < 0.01],且PV降低比PA更显著[差值(mmHg):69.20±6.55 vs. 13.20±5.45,P < 0.01]。
对于接受ECMO联合CRRT治疗的患者,将CRRT的血管通路连接至氧合器前或氧合器后,回血导管连接至回血导管点这一方案可显著降低PA和PV,即使在高流量ECMO运行时也能维持CRRT正常运行。